D-0516-2025 Class II Ongoing

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0516-2025 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jun 16, 2025 and is designated Class II. Reason for recall: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH). The recall status is ongoing. Affected quantity: 5,448 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 23, 2025
Initiation Date
Jun 16, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,448 bottles

Product description

Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88

Reason for recall

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).

Distribution pattern

Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.

Code information

Lot # AD42648, Exp 02/28/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0516-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0516-2025. Report a data issue: hello@regdatalab.com.